101 related articles for article (PubMed ID: 2389415)
1. Serum pancreatic elastase 1 as a marker of pancreatic graft damage.
Linder R; Sziegoleit A; Peters B; Brattström C; Tydén G; Groth CG
Transplant Proc; 1990 Aug; 22(4):1595. PubMed ID: 2389415
[No Abstract] [Full Text] [Related]
2. Posttransplant hyperamylasemia is associated with decreased patient and graft survival in pancreas allograft recipients.
Cheng SS; Munn SR
Transplant Proc; 1994 Apr; 26(2):428-9. PubMed ID: 7513452
[No Abstract] [Full Text] [Related]
3. Serum levels of pancreatic amylase and pancreas-specific protein as markers of pancreatic graft rejection episodes.
Minakawa R; Brattström C; Tydén G; Tibell A; Pousette A; Bergström K
Transplant Proc; 1995 Feb; 27(1):1329-30. PubMed ID: 7533379
[No Abstract] [Full Text] [Related]
4. Pancreatic exocrine dysfunction in maturity-onset diabetes of the young type 3.
Vesterhus M; Raeder H; Johansson S; Molven A; Njølstad PR
Diabetes Care; 2008 Feb; 31(2):306-10. PubMed ID: 17989309
[TBL] [Abstract][Full Text] [Related]
5. Characterization of early graft damage after pancreatic transplantation.
Büsing M; Hopt UT; Jochum M; Blumenstock I; Nader A
Transplant Proc; 1992 Jun; 24(3):811-2. PubMed ID: 1376526
[No Abstract] [Full Text] [Related]
6. Pancreatic elastase 1 after pancreatic transplantation.
Linder R; Sziegoleit A; Brattström C; Tydén G; Groth CG
Pancreas; 1991 Jan; 6(1):31-6. PubMed ID: 1704632
[TBL] [Abstract][Full Text] [Related]
7. Determination of elastase-1 serum levels in post ERCP/EST pancreatic damage.
Hardt PD; Fadgyas T; Kress O; Doppl WE; Weber HP; Bimler EA; Temme H; Klör HU
Z Gastroenterol; 1999 Aug; 37(8):701-5. PubMed ID: 10494604
[TBL] [Abstract][Full Text] [Related]
8. Effects of successful combined pancreatic and renal transplantation on advanced diabetic neuropathy: a one-year follow-up study.
Wilczek H; Solders G; Gunnarsson R; Tydén G; Persson A
Transplant Proc; 1987 Feb; 19(1 Pt 3):2327-8. PubMed ID: 3274516
[No Abstract] [Full Text] [Related]
9. Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation.
Ploeg RJ; D'Alessandro AM; Groshek M; Gange SJ; Knechtle SJ; Stegall MD; Eckhoff DE; Pirsch JD; Sollinger HW; Belzer FO
Transplant Proc; 1994 Apr; 26(2):531-3. PubMed ID: 7513455
[No Abstract] [Full Text] [Related]
10. ApoA1, ApoB, and ApoA1/ApoB before and after combined pancreas-kidney transplantation.
Larsen JL; Forsman JA; Miller SA; Taylor RJ; Stratta RJ
Transplant Proc; 1994 Apr; 26(2):503-4. PubMed ID: 8171526
[No Abstract] [Full Text] [Related]
11. Neutrophil activation detected by increased neutrophil elastase activity in type 1 (insulin-dependent) diabetes mellitus.
Collier A; Jackson M; Bell D; Patrick AW; Matthews DM; Young RJ; Clarke BF; Dawes J
Diabetes Res; 1989 Mar; 10(3):135-8. PubMed ID: 2805587
[TBL] [Abstract][Full Text] [Related]
12. Glucose disappearance constant (KG) provides an alternative diagnostic marker of acute pancreas allograft rejection.
Elmer DS; Hathaway DK; Shokouh-Amiri HM; Hughes TA; Gaber LW; Gaber AO
Transplant Proc; 1994 Apr; 26(2):536. PubMed ID: 7513456
[No Abstract] [Full Text] [Related]
13. Long-term metabolic effects of segmental pancreas transplantation.
Secchi A; Dubernard JM; Melandri M; Lefrancois N; Martinenghi S; Martin X; Traeger J; Pozza G
Transplant Proc; 1990 Aug; 22(4):1591-2. PubMed ID: 2389414
[No Abstract] [Full Text] [Related]
14. Pancreatic graft protects a simultaneously transplanted kidney from developing diabetic nephropathy: a 1- to 6-year follow-up study.
Wilczek HE; Jaremko G; Tydén G; Groth CG
Transplant Proc; 1993 Feb; 25(1 Pt 2):1314-5. PubMed ID: 8442125
[No Abstract] [Full Text] [Related]
15. Long-term pancreatic function: potential benefits.
Bartlett ST; delaTorre A; Johnson LB; Kuo PC; Schweitzer EJ
Transplant Proc; 1996 Aug; 28(4):2128-30. PubMed ID: 8769177
[No Abstract] [Full Text] [Related]
16. Impact of pancreatic pseudocysts in segmental duct-occluded pancreas transplants on graft function.
Candinas D; Schlumpf R; Roethlin M; Weder W; Largiadèr F
Transplant Proc; 1994 Apr; 26(2):456. PubMed ID: 8171500
[No Abstract] [Full Text] [Related]
17. Beta-cell dysfunction following successful segmental pancreas transplantation. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation.
Madsbad S; Christiansen E; Tibell A; Tydén G; Rasmussen K; Burcharth F
Transplant Proc; 1994 Apr; 26(2):469-70. PubMed ID: 8171509
[No Abstract] [Full Text] [Related]
18. Pancreas transplantation for diabetic patients in Hawaii.
Cheung AH; Limm WM; Wong LL
Hawaii Med J; 1994 Mar; 53(3):90-3. PubMed ID: 8005784
[TBL] [Abstract][Full Text] [Related]
19. Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection.
Grewal HP; Kotb M; Salem A; el Din AB; Novak K; Martin J; Gaber LW; Gaber AO
Transplant Proc; 1993 Feb; 25(1 Pt 1):132-5. PubMed ID: 7679807
[No Abstract] [Full Text] [Related]
20. Combined kidney/pancreas transplantation in diabetes mellitus.
Burke GW; Alejandro R; Nery J; Roth D; Skyler JS; Ricordi C; Ciancio G; Miller J
J Fla Med Assoc; 1994 May; 81(5):339-43. PubMed ID: 8046379
[No Abstract] [Full Text] [Related]
[Next] [New Search]
